Fingerprint
Dive into the research topics of 'A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically